These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


370 related items for PubMed ID: 29368599

  • 1. Effectiveness of nasal highflow in hypercapnic COPD patients is flow and leakage dependent.
    Bräunlich J, Mauersberger F, Wirtz H.
    BMC Pulm Med; 2018 Jan 24; 18(1):14. PubMed ID: 29368599
    [Abstract] [Full Text] [Related]

  • 2. Nasal highflow improves ventilation in patients with COPD.
    Bräunlich J, Köhler M, Wirtz H.
    Int J Chron Obstruct Pulmon Dis; 2016 Jan 24; 11():1077-85. PubMed ID: 27307723
    [Abstract] [Full Text] [Related]

  • 3. Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial.
    McKinstry S, Singer J, Baarsma JP, Weatherall M, Beasley R, Fingleton J.
    Respirology; 2019 Nov 24; 24(11):1081-1087. PubMed ID: 31083777
    [Abstract] [Full Text] [Related]

  • 4. Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD.
    Bräunlich J, Dellweg D, Bastian A, Budweiser S, Randerath W, Triché D, Bachmann M, Kähler C, Bayarassou AH, Mäder I, Geiseler J, Köhler N, Petroff D, Wirtz H.
    Int J Chron Obstruct Pulmon Dis; 2019 Nov 24; 14():1411-1421. PubMed ID: 31308647
    [Abstract] [Full Text] [Related]

  • 5. Nasal High Flow Use in COPD Patients with Hypercapnic Respiratory Failure: Treatment Algorithm & Review of the Literature.
    Pantazopoulos I, Daniil Z, Moylan M, Gourgoulianis K, Chalkias A, Zakynthinos S, Ischaki E.
    COPD; 2020 Feb 24; 17(1):101-111. PubMed ID: 31965868
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial.
    McKinstry S, Pilcher J, Bardsley G, Berry J, Van de Hei S, Braithwaite I, Fingleton J, Weatherall M, Beasley R.
    Respirology; 2018 Apr 24; 23(4):378-384. PubMed ID: 28940962
    [Abstract] [Full Text] [Related]

  • 8. Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial.
    Pantazopoulos I, Boutlas S, Mavrovounis G, Papalampidou A, Papagiannakis N, Kontou M, Bibaki E, Athanasiou N, Meletis G, Gourgoulianis K, Zakynthinos S, Ischaki E.
    Respir Med; 2024 Oct 24; 232():107762. PubMed ID: 39111544
    [Abstract] [Full Text] [Related]

  • 9. Nasal high flow reduces hypercapnia by clearance of anatomical dead space in a COPD patient.
    Fricke K, Tatkov S, Domanski U, Franke KJ, Nilius G, Schneider H.
    Respir Med Case Rep; 2016 Oct 24; 19():115-7. PubMed ID: 27668173
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of respiratory rate and size of cannula on pressure and dead-space clearance during nasal high flow in patients with COPD and acute respiratory failure.
    Pinkham MI, Domanski U, Franke KJ, Hartmann J, Schroeder M, Williams T, Nilius G, Tatkov S.
    J Appl Physiol (1985); 2022 Feb 01; 132(2):553-563. PubMed ID: 35085029
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of nasal high-flow oxygen in COPD patients.
    Vogelsinger H, Halank M, Braun S, Wilkens H, Geiser T, Ott S, Stucki A, Kaehler CM.
    BMC Pulm Med; 2017 Nov 17; 17(1):143. PubMed ID: 29149867
    [Abstract] [Full Text] [Related]

  • 15. Influence of effective noninvasive positive pressure ventilation on inflammatory and cardiovascular biomarkers in stable hypercapnic COPD patients.
    Dreher M, Schulte L, Müller T, Ekkernkamp E, Zirlik A.
    Respir Med; 2015 Oct 17; 109(10):1300-4. PubMed ID: 26341549
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nasal High-flow versus non-invasive ventilation in stable hypercapnic COPD: a preliminary report.
    Bräunlich J, Seyfarth HJ, Wirtz H.
    Multidiscip Respir Med; 2015 Oct 17; 10(1):27. PubMed ID: 26339486
    [Abstract] [Full Text] [Related]

  • 19. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: A randomized controlled cross-over trial.
    Pilcher J, Eastlake L, Richards M, Power S, Cripps T, Bibby S, Braithwaite I, Weatherall M, Beasley R.
    Respirology; 2017 Aug 17; 22(6):1149-1155. PubMed ID: 28470831
    [Abstract] [Full Text] [Related]

  • 20. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study.
    Biselli PJ, Kirkness JP, Grote L, Fricke K, Schwartz AR, Smith P, Schneider H.
    J Appl Physiol (1985); 2017 Jan 01; 122(1):82-88. PubMed ID: 27815367
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.